Matthew K Schindler

Dr. Matthew K Schindler

neurology, University of Pennsylvania, Philadelphia, Mississippi, USA
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
JCJohn N. Constantino
John N. Constantino
SDSandra A. Davis
Sandra A. Davis
RTRichard D. Todd
Richard D. Todd
MSMatthew K Schindler
Matthew K Schindler
MGMaggie M. Gross
Maggie M. Gross
WRWendy Reich
Wendy Reich

25 April 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
ICIrene Cortese
Irene Cortese
PMPawel Muranski
Pawel Muranski
YEYoshimi Enose-Akahata
Yoshimi Enose-Akahata
SHSeung-Kwon Ha
Seung-Kwon Ha
BSBryan Smith
Bryan Smith
ANAvindra Nath
Avindra Nath
Progressive multifocal leukoencephalopathy (PML) is an opportunistic brain infection that is caused by the JC virus and is typically fatal unless immune function can be restored. Programmed cell death protein 1 (PD-1) is a negative regulator of the immune response that may contribute to impaired viral clearance. Whether PD-1 blockade with pembrolizumab could reinvigorate anti–JC virus immune activity in patients with PML was unknown.

6 June 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MAMartina Absinta
Martina Absinta
PSPascal Sati
Pascal Sati
MSMatthew K Schindler
Matthew K Schindler
ELEmily C. Leibovitch
Emily C. Leibovitch
JOJoan Ohayon
Joan Ohayon
DRDaniel Reich
Daniel Reich
BACKGROUND. In some active multiple sclerosis (MS) lesions, a strong immune reaction at the lesion edge may contain growth and thereby isolate the lesion from the surrounding parenchyma. Our previous studies suggest that this process involves opening of the blood-brain barrier in capillaries at the lesion edge, seen on MRI as centripetal contrast enhancement and a colocalized phase rim. We hypothesized that using these features to characterize early lesion evolution will allow in vivo tracking of tissue degeneration and/or repair, thus improving the evaluation of potential therapies for chronic active lesions. METHODS. Centripetally and centrifugally enhancing lesions were studied in 17 patients with MS using 7-tesla MRI. High-resolution, susceptibility-weighted, T1-weighted (before/after gadolinium), and dynamic contrast–enhanced scans were acquired at baseline and months 1, 3, 6, and 12. For each lesion, time evolution of the phase rim, lesion volume, and T1 hypointensity were assessed. In autopsies of 3 progressive MS cases, the histopathology of the phase rim was determined. RESULTS. In centripetal lesions, a phase rim colocalized with initial contrast enhancement. In 12 of 22, this phase rim persisted after enhancement resolved. Compared with centripetal lesions with transient rim, those with persistent rim had less volume shrinkage and became more T1 hypointense between months 3 and 12. No centrifugal lesions developed phase rims at any time point. Pathologically, persistent rims corresponded to an iron-laden inflammatory myeloid cell population at the edge of chronic demyelinated lesions. CONCLUSION. In early lesion evolution, a persistent phase rim in lesions that shrink least and become more T1 hypointense over time suggests that the rim might mark failure of early lesion repair and/or irreversible tissue damage. In later stages of MS, phase rim lesions continue to smolder, exerting detrimental effects on affected brain tissue. TRIAL REGISTRATION. NCT00001248. FUNDING. The Intramural Research Program of NINDS supported this study.

3 May 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MAM. Absinta
M. Absinta
PSP. Sati
P. Sati
AFA. Fechner
A. Fechner
MSMatthew K Schindler
Matthew K Schindler
GNGovind Nair
Govind Nair
DRDaniel Reich
Daniel Reich
BACKGROUND AND PURPOSE: MR imaging–pathologic studies have reported that paramagnetic rims on 7T susceptibility-based MR imaging identify, in vivo, the subset of MS lesions with compartmentalized inflammation at the lesion edge and associated remyelination failure. Here, we assessed the reliability of detecting these rims on high-resolution 3T phase images. MATERIALS AND METHODS: High-resolution T2* and phase MR imaging was collected in 20 patients with MS at 3T (3D segmented EPI, 0.65 mm3) and 7T (2D gradient-echo, 0.2 × 0.2 × 1 mm) MR imaging. In each case, 5 discrete chronic (nonenhancing) MS lesions were selected on T2 FLAIR images for rim evaluation. Five raters experienced in MS imaging contributed to the rim assessment, of whom 3 worked independently on 3T data, and 2, on 7T data. Consensus agreement was reached for both 3T and 7T rim evaluations. Discrepancies between 3T and 7T were discussed, and consensus was reached. RESULTS: Phase rims were seen in 34 lesions at 7T and in 36 lesions at 3T by consensus. Inter- and intrarater reliability were “substantial/good” both at 3T and 7T analysis (Cohen κ, >0.71). Based on consensus agreement, the reliability of rim visualization at 3T versus 7T was 0.78 (κ) with a pair-wise agreement of 90%. More lesions were judged to be false-positive or false-negative at 3T than at 7T. CONCLUSIONS: Nearly all 7T paramagnetic rims can also be seen at 3T. Imaging at 3T opens the possibility of implementing paramagnetic rims as an outcome measure in multicenter, MR imaging–based clinical trials aimed at treating perilesional persistent inflammation and its potential effects on remyelination.

1 May 2004 in American Journal of Psychiatry
Verified
Journal Article
Closed access
JCJohn G. Csernansky
John G. Csernansky
MSMatthew K Schindler
Matthew K Schindler
NSN. Reagan Splinter
N. Reagan Splinter
LWLei Wang
Lei Wang
MGMohktar Gado
Mohktar Gado
MMMichael I. Miller
Michael I. Miller

1 December 2013 in NeuroImage
Verified
Journal Article
Closed access
SOSe-Hong Oh
Se-Hong Oh
MBMichel Bilello
Michel Bilello
MSMatthew K Schindler
Matthew K Schindler
CMClyde E. Markowitz
Clyde E. Markowitz
JDJohn A. Detre
John A. Detre
JLJongho Lee
Jongho Lee